Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
Dyne Therapeutics, Inc. (DYN) had Operating Cash Flow per Share of $-3.14 for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-446.21M |
|
-- |
|
-- |
|
$468.18M |
|
$-468.18M |
|
$21.97M |
|
$-446.21M |
|
$-446.21M |
|
$-446.21M |
|
$-446.21M |
|
$-446.21M |
|
$-446.21M |
|
$-468.18M |
|
$-467.97M |
|
128.44M |
|
128.44M |
|
$-3.47 |
|
$-3.47 |
|
| Balance Sheet Financials | |
$1.13B |
|
$24.03M |
|
$60.37M |
|
$1.19B |
|
$50.62M |
|
$148.92M |
|
$164.20M |
|
$214.83M |
|
$972.13M |
|
$972.13M |
|
$972.13M |
|
164.95M |
|
| Cash Flow Statement Financials | |
$-403.21M |
|
$-28.75M |
|
$890.31M |
|
$437.39M |
|
$895.74M |
|
$458.35M |
|
$45.85M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
22.25 |
|
-- |
|
-- |
|
0.13 |
|
0.15 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-405.13M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-45.90% |
|
-45.90% |
|
-37.59% |
|
-39.80% |
|
$5.89 |
|
$-3.15 |
|
|
Operating Cash Flow per Share |
$-3.14 |